TY - JOUR
T1 - Correlation of cerebral spinal fluid pH and HCO 3 - with disease progression in ALS
AU - Morimoto, Nobutoshi
AU - Deguchi, Kentaro
AU - Sato, Kota
AU - Yunoki, Taijun
AU - Deguchi, Shoko
AU - Ohta, Yasuyuki
AU - Kurata, Tomoko
AU - Takao, Yoshiki
AU - Ikeda, Yoshio
AU - Matsuura, Tohru
AU - Abe, Koji
N1 - Funding Information:
This work was partly supported by a Grant-in-Aid for Scientific Research (B) 21390267 and the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by grants (Itoyama Y, Imai T, Sobue G and Nakano I) from the Ministry of Health, Labour and Welfare of Japan.
PY - 2011/8/15
Y1 - 2011/8/15
N2 - Amyotrophic lateral sclerosis (ALS) is a progressive and fatal disease, which is characterized by progressive degeneration of spinal and bulbar innervating motor neurons. However, the underlying mechanisms of motor neuron death remain poorly understood. Several candidate disease biomarkers have been detected in cerebrospinal fluid of ALS patients. The present study analyzed various cerebral spinal fluid gas parameters in ALS patients and compared these values to controls, as well as patients with cervical spondylosis, Parkinson syndrome, and spinocerebellar degeneration. Cerebral spinal fluid pH positively correlated with the ALS functional rating scale in total and limb-type ALS patients. In addition, cerebral spinal fluid pH positively correlated with shorter disease duration (less than 22 weeks). These results suggested that cerebral spinal fluid pH provides a biomarker for ALS and could reflect mechanisms of disease progression in ALS patients.
AB - Amyotrophic lateral sclerosis (ALS) is a progressive and fatal disease, which is characterized by progressive degeneration of spinal and bulbar innervating motor neurons. However, the underlying mechanisms of motor neuron death remain poorly understood. Several candidate disease biomarkers have been detected in cerebrospinal fluid of ALS patients. The present study analyzed various cerebral spinal fluid gas parameters in ALS patients and compared these values to controls, as well as patients with cervical spondylosis, Parkinson syndrome, and spinocerebellar degeneration. Cerebral spinal fluid pH positively correlated with the ALS functional rating scale in total and limb-type ALS patients. In addition, cerebral spinal fluid pH positively correlated with shorter disease duration (less than 22 weeks). These results suggested that cerebral spinal fluid pH provides a biomarker for ALS and could reflect mechanisms of disease progression in ALS patients.
KW - Amyotrophic lateral sclerosis
KW - Cerebrospinal fluid
KW - Functional rating scale
KW - pH
UR - http://www.scopus.com/inward/record.url?scp=79959825042&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959825042&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2011.05.013
DO - 10.1016/j.jns.2011.05.013
M3 - Article
C2 - 21632065
AN - SCOPUS:79959825042
SN - 0022-510X
VL - 307
SP - 74
EP - 78
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
IS - 1-2
ER -